Does REGORAFENIB Cause Therapy non-responder? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Therapy non-responder have been filed in association with REGORAFENIB (Stivarga). This represents 0.1% of all adverse event reports for REGORAFENIB.
8
Reports of Therapy non-responder with REGORAFENIB
0.1%
of all REGORAFENIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy non-responder From REGORAFENIB?
Of the 8 reports.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which REGORAFENIB Alternatives Have Lower Therapy non-responder Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR